UC Physician Publishes Sports Dermatology Book
CINCINNATIEveryone knows that sports cause injuries, but what about skin problems?
There are plenty of them, according to University of Cincinnati (UC) dermatologist Brian Adams, MD, who has just published a book on the subject.
Titled Sports Dermatology, the book was originally aimed at dermatologists, sports medicine doctors, athletic trainers, nurses, pediatricians, family doctors and other medical professionals interested in skin conditions that affect athletes.
"But it will also be useful to parents, coaches, teachers, fitness trainers or anyone who considers sports and exercise a part of daily life, Adams says.
According to Adams, people participating in sports every day, whether on a team, in a gym or running or bicycling outdoors, risk sports-related skin problems. He says hes received so many questions from coaches, athletes, friends and colleagues that he decided to write the book to help simplify diagnosis, treatment and prevention of common and unusual sports-related skin conditions.
The book covers everything from viral, bacterial, fungal and parasitic skin infections to encounters with animals. Its five sections include infections, growths, inflammatory reactions, traumatic conditions and sports-related conditions induced by the environment. Sunburn, skin cancer, friction and pressure injuries, reactions to temperature, chemicals and anabolic steroids are also covered, as well as prevention plans for specific athletic activities.
"People always have books by the bedside, says Adams. "I hope this book will be available at the bench side.
Adams is an associate professor of dermatology at UC College of Medicine, chief of dermatology at the Cincinnati
The new book, Sports Dermatology, by Brian Adams, MD, discusses skin conditions that affect athletes.
Brian Adams, MD
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.